Loomis, Sayles & Company’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-32
| Closed | -$9K | – | 814 |
|
|
2023
Q4 | $9K | Buy |
+32
| New | +$7.91K | ﹤0.01% | 804 |
|
|
2023
Q3 | – | Sell |
-8
| Closed | -$2K | – | 954 |
|
|
2023
Q2 | $2K | Buy |
+8
| New | +$2.22K | ﹤0.01% | 944 |
|
|
2022
Q4 | – | Sell |
-9
| Closed | -$2K | – | 912 |
|
|
2022
Q3 | $2K | Sell |
9
-79
| -90% | -$15.7K | ﹤0.01% | 803 |
|
|
2022
Q2 | $15K | Sell |
88
-12
| -12% | -$2.58K | ﹤0.01% | 620 |
|
|
2022
Q1 | $25K | Sell |
100
-24
| -19% | -$6.03K | ﹤0.01% | 617 |
|
|
2021
Q4 | $32K | Sell |
124
-12
| -9% | -$2.94K | ﹤0.01% | 636 |
|
|
2021
Q3 | $33K | Buy |
136
+38
| +39% | +$9.29K | ﹤0.01% | 629 |
|
|
2021
Q2 | $20K | Sell |
98
-8,333
| -99% | -$1.7M | ﹤0.01% | 678 |
|
|
2021
Q1 | $1.59M | Sell |
8,431
-1,071
| -11% | -$189K | ﹤0.01% | 465 |
|
|
2020
Q4 | $1.56M | Buy |
9,502
+9,329
| +5,392% | +$1.36M | ﹤0.01% | 452 |
|
|
2020
Q3 | $22K | Buy |
+173
| New | +$21.4K | ﹤0.01% | 616 |
|
|
2020
Q2 | – | Sell |
-132
| Closed | -$12K | – | 709 |
|
|
2020
Q1 | $12K | Sell |
132
-410
| -76% | -$53.1K | ﹤0.01% | 656 |
|
|
2019
Q4 | $80K | Buy |
542
+46
| +9% | +$6.18K | ﹤0.01% | 611 |
|
|
2019
Q3 | $60K | Buy |
+496
| New | +$64.1K | ﹤0.01% | 656 |
|
|
2019
Q2 | – | Sell |
-124
| Closed | -$16K | – | 643 |
|
|
2019
Q1 | $16K | Sell |
124
-1,193
| -91% | -$160K | ﹤0.01% | 681 |
|
|
2018
Q4 | $164K | Buy |
+1,317
| New | +$177K | ﹤0.01% | 587 |
|
|
2016
Q1 | – | Sell |
-276,733
| Closed | -$18.7M | – | 1093 |
|
|
2015
Q4 | $18.7M | Sell |
276,733
-481,782
| -64% | -$33.6M | 0.05% | 309 |
|
|
2015
Q3 | $58.7M | Sell |
758,515
-89,142
| -11% | -$7.89M | 0.17% | 88 |
|
|
2015
Q2 | $76.9M | Buy |
847,657
+12,206
| +1% | +$978K | 0.21% | 79 |
|
|
2015
Q1 | $62.9M | Sell |
835,451
-98,553
| -11% | -$7.08M | 0.17% | 112 |
|
|
2014
Q4 | $68.5M | Sell |
934,004
-413,899
| -31% | -$29.1M | 0.19% | 108 |
|
|
2014
Q3 | $95.1M | Buy |
1,347,903
+259,335
| +24% | +$17.1M | 0.28% | 73 |
|
|
2014
Q2 | $61.4M | Sell |
1,088,568
-146,017
| -12% | -$7.7M | 0.17% | 129 |
|
|
2014
Q1 | $64.8M | Sell |
1,234,585
-5,842
| -0.5% | -$291K | 0.18% | 125 |
|
|
2013
Q4 | $59.2M | Sell |
1,240,427
-35,480
| -3% | -$1.64M | 0.18% | 131 |
|
|
2013
Q3 | $54.5M | Buy |
1,275,907
+99,192
| +8% | +$3.88M | 0.18% | 133 |
|
|
2013
Q2 | $42.4K | Buy |
+1,176,715
| New | +$45.5M | 0.15% | 162 |
|
Other funds holding HCA
Loomis, Sayles & Company's HCA Position: Q1 2024 in Review
Loomis, Sayles & Company sold out of HCA Healthcare (HCA) in Q1 2024, closing a stake of 32 shares — an estimated $9K sold.
Loomis, Sayles & Company first reported a position in HCA in Q2 2013 and held it in 27 quarters. The position peaked at $95.1M in Q3 2014. 1,126 funds tracked by Wall St. Rank hold HCA as of Q1 2024.
- Loomis, Sayles & Company reported no remaining HCA Healthcare position as of Q1 2024 after selling out during the quarter.
- Loomis, Sayles & Company sold 32 HCA Healthcare shares in Q1 2024, an estimated $9K.
- Loomis, Sayles & Company first reported a position in HCA Healthcare in Q2 2013 and held it in 27 quarters.
- Loomis, Sayles & Company's HCA Healthcare position peaked at $95.1M in Q3 2014.
- 1,126 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2024.
Based on Loomis, Sayles & Company's 13F filing for Q1 2024, filed 14 May 2024.